Pictet Asset Management (Switzerland)’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$4.81M Sell
120,277
-19,473
-14% -$774K 0.01% 779
2023
Q1
$5.49M Buy
139,750
+41,170
+42% +$1.51M 0.01% 769
2022
Q4
$3.14M Sell
98,580
-5,451
-5% -$164K ﹤0.01% 849
2022
Q3
$2.95M Buy
104,031
+1,378
+1% +$47.1K ﹤0.01% 842
2022
Q2
$3.67M Hold
102,653
0.01% 827
2022
Q1
$5.05M Sell
102,653
-2,036
-2% -$108K 0.01% 809
2021
Q4
$5.84M Buy
104,689
+483
+0.5% +$26.6K 0.01% 800
2021
Q3
$6.05M Buy
+104,206
New +$6.42M 0.01% 802

Other funds holding XRAY

Pictet Asset Management (Switzerland)'s XRAY Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Dentsply Sirona (XRAY) stake by 14% in Q2 2023, selling an estimated $774K and leaving 120,277 shares worth $4.81M. The position accounts for 0.01% of the portfolio, ranked #779.

Pictet Asset Management (Switzerland) first reported a position in XRAY in Q3 2021 and has held it in 8 quarters since. The position peaked at $6.05M in Q3 2021. 472 funds tracked by Wall St. Rank hold XRAY as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 120,277 shares of Dentsply Sirona worth $4.81M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 19,473 Dentsply Sirona shares in Q2 2023, an estimated $774K.
  • Dentsply Sirona made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #779 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Dentsply Sirona in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Dentsply Sirona position peaked at $6.05M in Q3 2021.
  • 472 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.